Stimulation of functional vessel growth by gene therapy

Integrative Biology

Volumn 2, Issue 2-3, 2010, Pages 102-112

  Korpisalo, Petra ^a   Yla Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; GENE DELIVERY SYSTEM; GENE EXPRESSION; PRIORITY JOURNAL; REVIEW; THERAPY;

ANIMALS; BLOOD VESSELS; GENE THERAPY; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 77953674872     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/b921869f     Document Type: Review

References (133)

1. L. Norgren W. R. Hiatt J. A. Dormandy M. R. Nehler K. A. Harris F. G. Fowkes K. Bell J. Caporusso I. Durand-Zaleski K. Komori J. Lammer C. Liapis S. Novo M. Razavi J. Robbs N. Schaper H. Shigematsu M. Sapoval C. White J. White D. Clement M. Creager M. Jaff E. Mohler III R. B. Rutherford P. Sheehan H. Sillesen K. Rosenfield Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur. J. Vasc. Endovasc. Surg. 2007 33 1 S1 75
2. P. Kuukasjarvi J. P. Salenius H. Riekkinen Acute ischemia of lower extremities Duodecim. 1997 113 31 37
3. A. Ide N. Baker S. Warren Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber Am. J. Roentgenol. 1939 42 891 899
4. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 1971 285 1182 1186
5. G. J. Svet-Moldavsky K. L. Chimishkyan Tumour angiogenesis factor for revascularisation in ischaemia and myocardial infarction Lancet 1977 309 913
6. S. Yla-Herttuala T. T. Rissanen I. Vajanto J. Hartikainen Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine J. Am. Coll. Cardiol. 2007 49 1015 1026
7. T. T. Rissanen S. Yla-Herttuala Current status of cardiovascular gene therapy Mol. Ther. 2007 15 1233 1247
8. J. D. Watson, M. Gilman, J. Witkowski and M. Zoller, Recombinant DNA, Scientific American books, Inc., New York, 1992
9. S. Yla-Herttuala K. Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat. Med. 2003 9 694 701
10. C. Sylven N. Sarkar P. Insulander G. Kenneback P. Blomberg K. Islam V. Drvota Catheter-based transendocardial myocardial gene transfer J. Interventional Cardiol. 2002 15 7 13
11. M. Laitinen T. Pakkanen E. Donetti R. Baetta J. Luoma P. Lehtolainen H. Viita R. Agrawal A. Miyanohara T. Friedmann W. Risau J. F. Martin M. Soma S. Ylä-Herttuala Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses Hum. Gene Ther. 1997 8 1645 1650
12. R. J. Lederman F. O. Mendelsohn R. D. Anderson J. F. Saucedo A. N. Tenaglia J. B. Hermiller W. B. Hillegass K. Rocha-Singh T. E. Moon M. J. Whitehouse B. H. Annex Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial Lancet 2002 359 2053 2058
13. M. O. Hiltunen M. P. Turunen A. M. Turunen T. T. Rissanen M. Laitinen V. M. Kosma S. Yla-Herttuala Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods FASEB J. 2000 14 2230 2236
14. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 2004 25 581 611 (Pubitemid 39099316)
15. A. C. Guyton and J. E. Hall, Textbook of Medical Physiology, W.B. Saunders, Philadelphia, 2000
16. T. J. Wickham Targeting adenovirus Gene Ther. 2000 7 110 114
17. J. Atencia D. J. Beebe Controlled microfluidic interfaces Nature 2005 437 648 655
18. J. M. Bergelson J. A. Cunningham G. Droguett E. A. Kurt-Jones A. Krithivas J. S. Hong M. S. Horwitz R. L. Crowell R. W. Finberg Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 1997 275 1320 1323
19. T. J. Wickham P. Mathias D. A. Cheresh G. R. Nemerow Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 1993 73 309 319
20. J. C. Grieger R. J. Samulski Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications Adv. Biochem. Eng. Biotechnol. 2005 99 119 45
21. B. M. Fadel S. C. Boutet T. Quertermous Functional analysis of the endothelial cell-specific Tie2/Tek promoter identifies unique protein-binding elements Biochem. J. 1998 330 335 343
22. A. Laurema A. Heikkila L. Keski-Nisula T. Heikura P. Lehtolainen H. Manninen T. T. Tuomisto S. Heinonen S. Yla-Herttuala Transfection of oocytes and other types of ovarian cells in rabbits after direct injection into uterine arteries of adenoviruses and plasmid/liposomes Gene Ther. 2003 10 580 584
23. J. Rutanen T. T. Rissanen J. E. Markkanen M. Gruchala P. Silvennoinen A. Kivela A. Hedman M. Hedman T. Heikura M. R. Orden S. A. Stacker M. G. Achen J. Hartikainen S. Yla-Herttuala Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart. Circulation 2004 109 1029 1035
24. M. J. Wright L. M. Wightman D. S. Latchman M. S. Marber In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo Gene Ther. 2001 8 1833 1839
25. I. Kovesdi D. E. Brough J. T. Bruder T. J. Wickham Adenoviral vectors for gene transfer Curr. Opin. Biotechnol. 1997 8 583 589
26. J. K. Raty H. P. Lesch T. Wirth S. Yla-Herttuala Improving safety of gene therapy Current Drug Safety 2008 3 46 53
27. D. A. Muruve The innate immune response to adenovirus vectors Hum. Gene Ther. 2004 15 1157 1166
28. P. Korpisalo, T. T. Rissanen and S. Ylä-Herttuala, The strengths and weaknesses of VEGF adenovirus-driven angiogenesis, in Therapeutic Neovascularization - Quo Vadis? ed., E. Deindl, and, C. Kupatt, Springer, 2007
29. W. Schaper D. Scholz Factors regulating arteriogenesis Arterioscler., Thromb., Vasc. Biol. 2003 23 1143 1151
30. S. Tafuro E. Ayuso S. Zacchigna L. Zentilin S. Moimas F. Dore M. Giacca Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression Cardiovasc. Res. 2009 83 663 671
31. M. Cavazzana-Calvo S. Hacein-Bey B. de Saint F. Gross E. Yvon P. Nusbaum F. Selz C. Hue S. Certain J. L. Casanova P. Bousso F. L. Deist A. Fischer Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 2000 288 669 672 (Pubitemid 30241569)
32. S. Hacein-Bey-Abina C. von Kalle M. Schmidt F. Le Deist N. Wulffraat E. McIntyre I. Radford J. L. Villeval C. C. Fraser M. Cavazzana-Calvo A. Fischer A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N. Engl. J. Med. 2003 348 255 256
33. D. W. Leung G. Cachianes W. J. Kuang D. V. Goeddel N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 1989 246 1306 1309
34. N. Ferrara W. J. Henzel Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem. Biophys. Res. Commun. 1989 161 851 858
35. B. Olofsson K. Pajusola A. Kaipainen G. von Euler V. Joukov O. Saksela A. Orpana R. F. Pettersson K. Alitalo U. Eriksson Vascular endothelial growth factor B, a novel growth factor for endothelial cells Proc. Natl. Acad. Sci. U. S. A. 1996 93 2576 2581 (Pubitemid 26104389)
36. V. Joukov K. Pajusola A. Kaipainen D. Chilov I. Lahtinen E. Kukk O. Saksela N. Kalkkinen K. Alitalo A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO J. 1996 15 290 298
37. Y. Yamada J. Nezu M. Shimane Y. Hirata Molecular cloning of a novel vascular endothelial growth factor, VEGF-D Genomics 1997 42 483 488
38. S. Ogawa A. Oku A. Sawano S. Yamaguchi Y. Yazaki M. Shibuya A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain J. Biol. Chem. 1998 273 31273 31282
39. D. J. Lyttle K. M. Fraser S. B. Fleming A. A. Mercer A. J. Robinson Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus J. Virol. 1994 68 84 92
40. Y. Yamazaki Y. Tokunaga K. Takani T. Morita Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165 Biochemistry 2005 44 8858 8864
41. D. Maglione V. Guerriero G. Viglietto P. Delli-Bovi M. G. Persico Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor Proc. Natl. Acad. Sci. U. S. A. 1991 88 9267 9271
42. P. Carmeliet V. Ferreira G. Breier S. Pollefeyt L. Kieckens M. Gertsenstein M. Fahrig A. Vandenhoeck K. Harpal C. Eberhardt C. Declercq J. Pawling L. Moons D. Collen W. Risau A. Nagy Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 1996 380 435 439
43. N. Ferrara K. Carver-Moore H. Chen M. Dowd L. Lu K. S. O'Shea L. Powell-Braxton K. J. Hillan M. W. Moore Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 1996 380 439 442
44. E. Storkebaum D. Lambrechts P. Carmeliet VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection BioEssays 2004 26 943 954
45. D. Bellomo J. P. Headrick G. U. Silins C. A. Paterson P. S. Thomas M. Gartside A. Mould M. M. Cahill I. D. Tonks S. M. Grimmond S. Townson C. Wells M. Little M. C. Cummings N. K. Hayward G. F. Kay Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia Circ. Res. 2000 86 E29 E35
46. K. Aase G. von Euler X. Li A. Ponten P. Thoren R. Cao Y. Cao B. Olofsson S. Gebre-Medhin M. Pekny K. Alitalo C. Betsholtz U. Eriksson Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect Circulation 2001 104 358 364
47. A. W. Mould I. D. Tonks M. M. Cahill A. R. Pettit R. Thomas N. K. Hayward G. F. Kay Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis Arthritis Rheum. 2003 48 2660 2669
48. X. Li M. Tjwa H. I. Van B. Enholm E. Neven K. Paavonen M. Jeltsch T. D. Juan R. E. Sievers E. Chorianopoulos H. Wada M. Vanwildemeersch A. Noel J. M. Foidart M. L. Springer G. von Degenfeld M. Dewerchin H. M. Blau K. Alitalo U. Eriksson P. Carmeliet L. Moons Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium Arterioscler., Thromb., Vasc. Biol. 2008 28 1614 1620
49. J. E. Lahteenvuo M. T. Lahteenvuo A. Kivela C. Rosenlew A. Falkevall J. Klar T. Heikura T. T. Rissanen E. Vahakangas P. Korpisalo B. Enholm P. Carmeliet K. Alitalo U. Eriksson S. Yla-Herttuala Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms Circulation 2009
50. S. A. Stacker K. Stenvers C. Caesar A. Vitali T. Domagala E. Nice S. Roufail R. J. Simpson R. Moritz T. Karpanen K. Alitalo M. G. Achen Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers J. Biol. Chem. 1999 274 32127 32136
51. T. T. Rissanen J. E. Markkanen M. Gruchala T. Heikura A. Puranen M. I. Kettunen I. Kholova R. A. Kauppinen M. G. Achen S. A. Stacker K. Alitalo S. Yla-Herttuala VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Circ. Res. 2003 92 1098 1106
52. L. M. Wise T. Veikkola A. A. Mercer L. J. Savory S. B. Fleming C. Caesar A. Vitali T. Makinen K. Alitalo S. A. Stacker Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1 Proc. Natl. Acad. Sci. U. S. A. 1999 96 3071 3076
53. A. Kiba H. Sagara T. Hara M. Shibuya VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice Biochem. Biophys. Res. Commun. 2003 301 371 377
54. Y. Yamazaki K. Takani H. Atoda T. Morita Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2) J. Biol. Chem. 2003 278 51985 51988
55. K. Hattori B. Heissig Y. Wu S. Dias R. Tejada B. Ferris D. J. Hicklin Z. Zhu P. Bohlen L. Witte J. Hendrikx N. R. Hackett R. G. Crystal M. A. Moore Z. Werb D. Lyden S. Rafii Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment Nat. Med. 2002 8 841 849
56. F. Pipp M. Heil K. Issbrucker T. Ziegelhoeffer S. Martin H. J. Van Den H. Weich B. Fernandez G. Golomb P. Carmeliet W. Schaper M. Clauss VEGFR-1-selective VEGF homologue PlGF is arteriogenic. Evidence for a monocyte-mediated mechanism Circ. Res. 2003 92 378 385
57. P. Carmeliet L. Moons A. Luttun V. Vincenti V. Compernolle M. De Mol Y. Wu F. Bono L. Devy H. Beck D. Scholz T. Acker T. DiPalma M. Dewerchin A. Noel I. Stalmans A. Barra S. Blacher T. Vandendriessche A. Ponten U. Eriksson K. H. Plate J. M. Foidart W. Schaper D. S. Charnock-Jones D. J. Hicklin J. M. Herbert D. Collen M. G. Persico Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 2001 7 575 583
58. T. Odorisio C. Schietroma M. L. Zaccaria F. Cianfarani C. Tiveron L. Tatangelo C. M. Failla G. Zambruno Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability J. Cell Sci. 2002 115 2559 2567
59. H. Oura J. Bertoncini P. Velasco L. F. Brown P. Carmeliet M. Detmar A critical role of placental growth factor in the induction of inflammation and edema formation Blood 2003 101 560 567
60. J. E. Lahteenvuo M. T. Lahteenvuo A. Kivela C. Rosenlew A. Falkevall J. Klar T. Heikura T. T. Rissanen E. Vahakangas P. Korpisalo B. Enholm P. Carmeliet K. Alitalo U. Eriksson S. Yla-Herttuala Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms Circulation 2009 119 845 856
61. T. T. Rissanen J. E. Markkanen K. Arve J. Rutanen M. I. Kettunen I. Vajanto S. Jauhiainen L. Cashion M. Gruchala O. Narvanen P. Taipale R. A. Kauppinen G. M. Rubanyi S. Yla-Herttuala Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model FASEB J. 2003 17 100 102
62. D. M. Ornitz J. Xu J. S. Colvin D. G. McEwen C. A. MacArthur F. Coulier G. Gao M. Goldfarb Receptor specificity of the fibroblast growth factor family J. Biol. Chem. 1996 271 15292 15297
63. G. T. Stavri I. C. Zachary P. A. Baskerville J. F. Martin J. D. Erusalimsky Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia Circulation 1995 92 11 14
64. J. C. Tille J. Wood S. J. Mandriota C. Schnell S. Ferrari J. Mestan Z. Zhu L. Witte M. S. Pepper Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro J. Pharmacol. Exp. Ther. 2001 299 1073 1085
65. M. Murakami M. Simons Fibroblast growth factor regulation of neovascularization Curr. Opin. Hematol. 2008 15 215 220
66. M. Sleeman J. Fraser M. McDonald S. Yuan D. White P. Grandison K. Kumble J. D. Watson J. G. Murison Identification of a new fibroblast growth factor receptor, FGFR5 Gene 2001 271 171 182
67. Z. Yablonka-Reuveni R. Seger A. J. Rivera Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats J. Histochem. Cytochem. 1999 47 23 42
68. R. Ross J. Glomset B. Kariya L. Harker A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro Proc. Natl. Acad. Sci. U. S. A. 1974 71 1207 1210
69. C. H. Heldin B. Westermark A. Wasteson Platelet-derived growth factor: purification and partial characterization Proc. Natl. Acad. Sci. U. S. A. 1979 76 3722 3726
70. H. N. Antoniades C. D. Scher C. D. Stiles Purification of human platelet-derived growth factor Proc. Natl. Acad. Sci. U. S. A. 1979 76 1809 1813
71. M. Tallquist A. Kazlauskas PDGF signaling in cells and mice Cytokine Growth Factor Rev. 2004 15 205 213
72. T. F. Deuel J. S. Huang R. T. Proffitt J. U. Baenziger D. Chang B. B. Kennedy Human platelet-derived growth factor. Purification and resolution into two active protein fractions J. Biol. Chem. 1981 256 8896 8899
73. D. T. Bonthron C. C. Morton S. H. Orkin T. Collins Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing Proc. Natl. Acad. Sci. U. S. A. 1988 85 1492 1496
74. T. Collins D. Ginsburg J. M. Boss S. H. Orkin J. S. Pober Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis Nature 1985 316 748 750 (Pubitemid 16239356)
75. X. Li A. Ponten K. Aase L. Karlsson A. Abramsson M. Uutela G. Backstrom M. Hellstrom H. Bostrom H. Li P. Soriano C. Betsholtz C. H. Heldin K. Alitalo A. Ostman U. Eriksson PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor Nat. Cell Biol. 2000 2 302 309
76. W. J. LaRochelle M. Jeffers W. F. McDonald R. A. Chillakuru N. A. Giese N. A. Lokker C. Sullivan F. L. Boldog M. Yang C. Vernet C. E. Burgess E. Fernandes L. L. Deegler B. Rittman J. Shimkets R. A. Shimkets J. M. Rothberg H. S. Lichenstein PDGF-D, a new protease-activated growth factor Nat. Cell Biol. 2001 3 517 521
77. E. Bergsten M. Uutela X. Li K. Pietras A. Ostman C. H. Heldin K. Alitalo U. Eriksson PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor Nat. Cell Biol. 2001 3 512 516
78. K. Levanon N. Varda-Bloom S. Greenberger I. Barshack I. Goldberg A. Orenstein E. Breitbart A. Shaish D. Harats Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression Pathobiology 2006 73 149 158
79. T. P. Richardson M. C. Peters A. B. Ennett D. J. Mooney Polymeric system for dual growth factor delivery Nat. Biotechnol. 2001 19 1029 1034
80. P. Lindblom H. Gerhardt S. Liebner A. Abramsson M. Enge M. Hellstrom G. Backstrom S. Fredriksson U. Landegren H. C. Nystrom G. Bergstrom E. Dejana A. Ostman P. Lindahl C. Betsholtz Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall Genes Dev. 2003 17 1835 1840
81. M. Bjarnegard M. Enge J. Norlin S. Gustafsdottir S. Fredriksson A. Abramsson M. Takemoto E. Gustafsson R. Fassler C. Betsholtz Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities Development 2004 131 1847 1857
82. A. Abramsson P. Lindblom C. Betsholtz Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors J. Clin. Invest. 2003 112 1142 1151
83. P. Korpisalo H. Karvinen T. T. Rissanen J. Kilpijoki V. Marjomaki P. Baluk D. M. McDonald Y. Cao U. Eriksson K. Alitalo S. Yla-Herttuala Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-B Combination Gene Therapy Prolongs Angiogenic Effects via Recruitment of Interstitial Mononuclear Cells and Paracrine Effects Rather Than Improved Pericyte Coverage of Angiogenic Vessels Circ. Res. 2008 103 1092 1099
84. E. Millette B. H. Rauch O. Defawe R. D. Kenagy G. Daum A. W. Clowes Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation Circ. Res. 2005 96 172 179
85. M. R. Kano Y. Morishita C. Iwata S. Iwasaka T. Watabe Y. Ouchi K. Miyazono K. Miyazawa VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling J. Cell Sci. 2005 118 3759 3768
86. S. Davis T. H. Aldrich P. F. Jones A. Acheson D. L. Compton V. Jain T. E. Ryan J. Bruno C. Radziejewski P. C. Maisonpierre G. D. Yancopoulos Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning Cell 1996 87 1161 1169 (Pubitemid 27010100)
87. G. Thurston C. Suri K. Smith J. McClain T. N. Sato G. D. Yancopoulos D. M. McDonald Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 1999 286 2511 2514
88. T. Hawighorst M. Skobe M. Streit Y. K. Hong P. Velasco L. F. Brown L. Riccardi B. Lange-Asschenfeldt M. Detmar Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth Am. J. Pathol. 2002 160 1381 1392
89. P. C. Maisonpierre C. Suri P. F. Jones S. Bartunkova S. J. Wiegand C. Radziejewski D. Compton J. McClain T. H. Aldrich N. Papadopoulos T. J. Daly S. Davis T. N. Sato G. D. Yancopoulos Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 1997 277 55 60
90. A. Papapetropoulos D. Fulton K. Mahboubi R. G. Kalb D. S. O'Connor F. Li D. C. Altieri W. C. Sessa Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway J. Biol. Chem. 2000 275 9102 9105
91. K. G. Shyu O. Manor M. Magner G. D. Yancopoulos J. M. Isner Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb Circulation 1998 98 2081 2087
92. J. K. Chae I. Kim S. T. Lim M. J. Chung W. H. Kim H. G. Kim J. K. Ko G. Y. Koh Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization Arterioscler. Thromb. Vasc. Biol. 2000 20 2573 2578
93. C. Suri J. McClain G. Thurston D. M. McDonald H. Zhou E. H. Oldmixon T. N. Sato G. D. Yancopoulos Increased vascularization in mice overexpressing angiopoietin-1 Science 1998 282 468 471
94. R. P. Visconti C. D. Richardson T. N. Sato Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF) Proc. Natl. Acad. Sci. U. S. A. 2002 99 8219 8224
95. W. S. Shim M. Teh A. Bapna I. Kim G. Y. Koh P. O. Mack R. Ge Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice Exp. Cell Res. 2002 279 299 309
96. I. B. Lobov P. C. Brooks R. A. Lang Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo Proc. Natl. Acad. Sci. U. S. A. 2002 99 11205 11210
97. N. W. Gale G. Thurston S. F. Hackett R. Renard Q. Wang J. McClain C. Martin C. Witte M. H. Witte D. Jackson C. Suri P. A. Campochiaro S. J. Wiegand G. D. Yancopoulos Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 Dev. Cell 2002 3 411 423
98. G. Dong Z. Chen Z. Y. Li N. T. Yeh C. C. Bancroft C. Van Waes Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma Cancer Res. 2001 61 5911 5918
99. K. Pajusola J. Kunnapuu S. Vuorikoski J. Soronen H. Andre T. Pereira P. Korpisalo S. Yla-Herttuala L. Poellinger K. Alitalo Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer FASEB J. 2005 19 1365 1367
100. L. S. Brevetti D. S. Chang G. L. Tang R. Sarkar L. M. Messina Overexpression of endothelial nitric oxide synthase increases skeletal muscle blood flow and oxygenation in severe rat hind limb ischemia J. Vasc. Surg. 2003 38 820 826
101. R. Cooney S. O. Hynes A. M. Duffy F. Sharif T. O'Brien Adenoviral-mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation J. Vasc. Res. 2006 43 462 472
102. W. Risau I. Flamme Vasculogenesis Annu. Rev. Cell Dev. Biol. 1995 11 73 91
103. S. Rafii D. Lyden Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 2003 9 702 712
104. T. Asahara T. Murohara A. Sullivan M. Silver R. van der Zee T. Li B. Witzenbichler G. Schatteman J. M. Isner Isolation of putative progenitor endothelial cells for angiogenesis Science 1997 275 964 967
105. J. Rehman J. Li C. M. Orschell K. L. March Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors Circulation 2003 107 1164 1169
106. S. Purhonen J. Palm D. Rossi N. Kaskenpaa I. Rajantie S. Yla-Herttuala K. Alitalo I. L. Weissman P. Salven Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Proc. Natl. Acad. Sci. U. S. A. 2008 105 6620 6625
107. J. Kastrup R. S. Ripa Y. Wang E. Jorgensen Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy? Eur. Heart J. 2006 27 2748 2754
108. E. M. Conway D. Collen P. Carmeliet Molecular mechanisms of blood vessel growth Cardiovasc. Res. 2001 49 507 521
109. W. Risau Mechanisms of angiogenesis Nature 1997 386 671 674
110. T. T. Rissanen P. Korpisalo J. E. Markkanen T. Liimatainen M. R. Orden I. Kholova A. de Goede T. Heikura O. H. Grohn S. Yla-Herttuala Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis Circulation 2005 112 25 3937 3946
111. I. Vajanto P. Korpisalo J. Karjalainen T. Hakala K. Mäkinen S. Ylä-Herttuala Antegrade flow and peripheral resistance determine the level of endogenous arteriogenesis in patients with superficial femoral artery occlusion Eur. J. Clin. Invest. 2009 39 1048 1054
112. F. C. White C. M. Bloor M. D. McKirnan S. M. Carroll Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart J. Appl. Physiol. 1998 85 1160 1168
113. I. E. Hoefer N. van Royen I. R. Buschmann J. J. Piek W. Schaper Time course of arteriogenesis following femoral artery occlusion in the rabbit Cardiovasc. Res. 2001 49 609 617
114. K. Callum A. Bradbury Acute limb ischaemia Br. Med. J. 2000 320 764 767
115. I. Baumgartner G. Rauh A. Pieczek D. Wuensch M. Magner M. Kearney R. Schainfeld J. M. Isner Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor Ann. Intern. Med. 2000 132 880 884
116. M. Nauck G. Karakiulakis A. P. Perruchoud E. Papakonstantinou M. Roth Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells Eur. J. Pharmacol. 1998 341 309 315
117. P. R. Whitlock N. R. Hackett P. L. Leopold T. K. Rosengart R. G. Crystal Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs Mol. Ther. 2004 9 67 75
118. X. Hao E. A. Silva A. Mansson-Broberg K. H. Grinnemo A. J. Siddiqui G. Dellgren E. Wardell L. A. Brodin D. J. Mooney C. Sylven Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction Cardiovasc. Res. 2007 75 178 185
119. Y. Dor V. Djonov R. Abramovitch A. Itin G. I. Fishman P. Carmeliet G. Goelman E. Keshet Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy EMBO J. 2002 21 1939 1947
120. S. Zacchigna E. Tasciotti C. Kusmic N. Arsic O. Sorace C. Marini P. Marzullo S. Pardini D. Petroni L. Pattarini S. Moimas M. Giacca G. Sambuceti In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature Hum. Gene Ther. 2007 18 515 524
121. K. Makinen H. Manninen M. Hedman P. Matsi H. Mussalo E. Alhava S. Yla-Herttuala Increased Vascularity Detected by Digital Subtraction Angiography after VEGF Gene Transfer to Human Lower Limb Artery: A Randomized, Placebo-Controlled, Double-Blinded Phase II Study Mol. Ther. 2002 6 127 133
122. J. C. Miller H. H. Pien D. Sahani A. G. Sorensen J. H. Thrall Imaging angiogenesis: applications and potential for drug development J. Natl. Cancer Inst. 2005 97 172 187
123. T. T. Rissanen P. Korpisalo H. Karvinen T. Liimatainen S. Laidinen O. Gröhn S. Ylä-Herttuala High-Resolution Ultrasound Perfusion Imaging of Therapeutic Angiogenesis Journal of American College of Cardiology: Cardiovascular Imaging 2008 1 83 91
124. M. Krix M. A. Weber H. Krakowski-Roosen H. B. Huttner S. Delorme H. U. Kauczor W. Hildebrandt Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography J. Ultrasound Med. 2005 24 431 441
125. A. Saraste S. G. Nekolla M. Schwaiger Cardiovascular molecular imaging: an overview Cardiovasc. Res. 2009 83 643 652
126. J. J. Rychak J. Graba A. M. Cheung B. S. Mystry J. R. Lindner R. S. Kerbel F. S. Foster Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis Mol. Imaging 2007 6 289 296
127. M. Rodriguez-Porcel W. Cai O. Gheysens J. K. Willmann K. Chen H. Wang I. Y. Chen L. He J. C. Wu Z. B. Li K. A. Mohamedali S. Kim M. G. Rosenblum X. Chen S. S. Gambhir Imaging of VEGF receptor in a rat myocardial infarction model using PET J. Nucl. Med. 2008 49 667 673
128. D. B. Ellegala H. Leong-Poi J. E. Carpenter A. L. Klibanov S. Kaul M. E. Shaffrey J. Sklenar J. R. Lindner Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3 Circulation 2003 108 336 341
129. D. C. Isbell S. S. Berr A. Y. Toledano F. H. Epstein C. H. Meyer W. J. Rogers N. L. Harthun K. D. Hagspiel A. Weltman C. M. Kramer Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease J. Am. Coll. Cardiol. 2006 47 2289 2295
130. M. Simons R. O. Bonow N. A. Chronos D. J. Cohen F. J. Giordano H. K. Hammond R. J. Laham W. Li M. Pike F. W. Sellke T. J. Stegmann J. E. Udelson T. K. Rosengart Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary Circulation 2000 102 E73 E86
131. P. Korpisalo T. T. Rissanen T. Bengtsson T. Liimatainen S. Laidinen H. Karvinen J. E. Markkanen O. H. Grohn S. Yla-Herttuala Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs Cardiovasc. Res. 2008 80 263 270
132. S. S. Gambhir M. Schwaiger S. C. Huang J. Krivokapich H. R. Schelbert C. A. Nienaber M. E. Phelps Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose J. Nucl. Med. 1989 30 359 366
133. V. Dilsizian T. M. Bateman S. R. Bergmann P. R. Des M. Y. Magram A. E. Goodbody J. W. Babich J. E. Udelson Metabolic imaging with beta-methyl-p-[(123) I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia Circulation 2005 112 2169 2174